NEWS

INR stories: Jacques Moret's uncensored interview

Is NCCT powered by AI the future of acute stroke triage?

Bifurcation challenges in unruptured MCA aneurysm

Beyond sizing: can simulation help predict aneurysm treatment outcomes?

First-Pass Complete Reperfusion of a Left Carotid-T Occlusion

Y-Stent-assisted coiling for Left MCA bifurcation aneurysm

The evolution and future of Surgical Robotics

Galaxy Therapeutics Achieves CE Mark for SEAL™ Embolization System, Enab...

Galaxy Therapeutics, a privately held medical device company dedicated to advancing the treatment of intracranial aneurysms, today announced that it has received CE Mark under the European Medical Device Regulation (EU MDR 2017/745) for the SEAL™ Embolization System, following successful assessment by Notified Body DQS Medizinprodukte GmbH.

Acandis Receives Regulatory Approval to Launch SONIC Pivotal Clinical In...

Acandis GmbH, a leading Germany medical technology company specialising in devices for neurovascular interventions, announced today that it has received approval from the German Federal Institute for Drugs and Medical Devices (BfArM) to initiate the SONIC clinical investigation in Germany.

“Slow-deconstructive” approach in a patient with acute stroke and fusiform MCA aneurysm